TrialPloS one2020

Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission.

Patience Nyakato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.